ArticleMolecular therapy : the journal of the American Society of Gene Therapy2022

First-in-human in vivo genome editing via AAV-zinc-finger nucleases for mucopolysaccharidosis I/II and hemophilia B.

Paul Harmatz et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.